Published in Transplantation on March 15, 1997
Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation. Lipids Health Dis (2009) 0.85
Hypercholesterolemia and apolipoprotein B expression: regulation by selenium status. Lipids Health Dis (2005) 0.81
Vitamin E in renal therapeutic regiments. Pediatr Nephrol (2006) 0.79
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest (1998) 3.34
Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol (1992) 2.68
Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med (1997) 2.10
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr (2000) 2.07
Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol (Oxf) (2001) 1.99
Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med (1999) 1.80
Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr (1995) 1.74
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J (2011) 1.63
Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res (2002) 1.62
Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation (2000) 1.61
Polyuridylic acid binding and translating by Escherichia coli ribosomes: stimulation by protein I, inhibition by aurintricarboxylic acid. Biochim Biophys Acta (1972) 1.60
Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol (1998) 1.59
Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol (1997) 1.58
Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant (2001) 1.53
Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol (1999) 1.47
Trampoline use as physiotherapy for cystic fibrosis patients. Pediatr Pulmonol (2005) 1.42
Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes. Eur J Clin Invest (1997) 1.42
SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents. Mol Cell Biol (1999) 1.32
Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr (1996) 1.30
Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. Atherosclerosis (1998) 1.21
Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr (2001) 1.20
Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr (1997) 1.16
Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem Med (1983) 1.13
Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc Natl Acad Sci U S A (1989) 1.12
On the physiological role(s) of the paraoxonases. Chem Biol Interact (1999) 1.09
Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arterioscler Thromb Vasc Biol (2001) 1.07
Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol (2001) 1.04
Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun (1997) 1.02
Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem Biophys Res Commun (1994) 1.02
Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem (1982) 1.02
The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation. Genomics (1998) 1.02
Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics (1999) 1.00
Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice. Biochem Biophys Res Commun (1994) 0.99
Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut (1996) 0.98
Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid Redox Signal (2000) 0.98
Platelet function in a case with abetalipoproteinemia. Atherosclerosis (1985) 0.97
Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patients. Clin Cardiol (1989) 0.97
Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism (1991) 0.96
Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis (1995) 0.96
Expression, purification, and biochemical characterization of SAG, a ring finger redox-sensitive protein. Free Radic Biol Med (1999) 0.96
Low density lipoprotein binding to human platelets: role of charge and of specific amino acids. Biochem Biophys Res Commun (1981) 0.95
Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis (1994) 0.95
Normolipidemic xanthelasma palpebrarum: lipid composition, cholesterol metabolism in monocyte-derived macrophages, and plasma lipid peroxidation. Acta Derm Venereol (1996) 0.94
Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics (1999) 0.94
Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism (1996) 0.94
The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis (1998) 0.94
Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis. Br J Rheumatol (1985) 0.93
Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med (1999) 0.93
The effect of human plasma on platelet function in familial hypercholesterolemia. Thromb Res (1982) 0.93
Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein. Endocrinology (1992) 0.91
Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies. Free Radic Biol Med (1998) 0.90
Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Radic Biol Med (1998) 0.90
Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol (2005) 0.89
Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia. Clin Sci (Lond) (1983) 0.89
Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus. Ann Nutr Metab (2000) 0.89
Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic Res (2001) 0.88
Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6. Arterioscler Thromb Vasc Biol (2001) 0.88
Platelet interaction with high and low density lipoproteins. Atherosclerosis (1983) 0.88
Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients. Biochem Biophys Res Commun (2000) 0.88
Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis (1999) 0.87
The effect of blood constituents on platelet function: role of blood cells and plasma lipoproteins. Artery (1983) 0.87
Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis (1992) 0.87
Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Atherosclerosis (1997) 0.87
Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol. Arterioscler Thromb Vasc Biol (1995) 0.87
Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols. Biochem Biophys Res Commun (2000) 0.86
White wine with red wine-like properties: increased extraction of grape skin polyphenols improves the antioxidant capacity of the derived white wine. J Agric Food Chem (2001) 0.86
HDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein: studies in transgenic mice. Eur J Clin Chem Clin Biochem (1995) 0.86
Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. Metabolism (1994) 0.85
Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl ester. J Lipid Res (1994) 0.85
A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. Am J Respir Crit Care Med (1997) 0.85
Interlayer coherent composite Fermi liquid phase in quantum Hall bilayers. Phys Rev Lett (2009) 0.85
Macrophage released proteoglycans are involved in cell-mediated aggregation of LDL. Atherosclerosis (1999) 0.85
Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy. J Cardiovasc Pharmacol (1998) 0.85
Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical events. Arterioscler Thromb (1991) 0.85
Vortices and quasiparticles near the superconductor-insulator transition in thin films. Phys Rev Lett (2005) 0.84
Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation. Eur J Clin Invest (1984) 0.84
Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells. Biochem Biophys Res Commun (1998) 0.84
Increased susceptibility to activation and increased uptake of low density lipoprotein by cholesterol-loaded macrophages. Arterioscler Thromb (1992) 0.83
Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis. N Engl J Med (1978) 0.83
Increased low-density lipoprotein levels after splenectomy: a role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am J Med Sci (1986) 0.83
Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron (1986) 0.83
Enhanced lipid oxidation by oxidatively modified myoglobin: role of protein-bound heme. Biochem Biophys Res Commun (2000) 0.82
9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells. Arterioscler Thromb Vasc Biol (1999) 0.82
Platelet activation by plasma lipoproteins. Prog Cardiovasc Dis (1987) 0.82
Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C. J Biol Chem (1999) 0.82
Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic Biol Med (1997) 0.82
Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL. Metabolism (1992) 0.82
Serum lipoprotein profile in children with celiac disease. J Pediatr Gastroenterol Nutr (1990) 0.81
Fatal multiple organ failure following massive hornet stings. J Toxicol Clin Toxicol (1995) 0.81
Systemic inflammatory mediators and cystic fibrosis genotype. Clin Exp Med (2004) 0.81
Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS). Clin Exp Immunol (1997) 0.81
Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol. Br J Clin Pharmacol (1983) 0.81
Characterization of the effect of plasma lipoproteins on platelet function in vitro. Haemostasis (1983) 0.81